PubRank

Patrick Petignat

Author PubWeight™ 40.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 2006 1.96
2 Levator ani muscle complex: anatomic findings in nulliparous patients at thin-section MR imaging with double opacification. Radiology 2011 1.37
3 Use of Smartphones as Adjuvant Tools for Cervical Cancer Screening in Low-Resource Settings. J Low Genit Tract Dis 2015 1.27
4 Women's health 18 years after rupture of the anal sphincter during childbirth: I. Fecal incontinence. Am J Obstet Gynecol 2006 1.14
5 Laparoscopic "Successful" Excision of Deep Endometriosis: A Fertility-enhancing Surgery. Ann Surg 2015 1.08
6 Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J Clin Microbiol 2012 1.05
7 Intracorporeal electromechanical tissue morcellation: a critical review and recommendations for clinical practice. Obstet Gynecol 2015 1.05
8 Early-stage cervical cancer: is surgery better than radiotherapy? Expert Rev Anticancer Ther 2010 1.04
9 Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Womens Health 2011 1.02
10 Gynecological malignancies in Maroua, Cameroon. Int J Gynaecol Obstet 2008 0.97
11 Is it time to introduce HPV self-sampling for primary cervical cancer screening? J Natl Cancer Inst 2012 0.96
12 Primary abdominal wall clear cell carcinoma: case report and review of literature. Anticancer Res 2009 0.95
13 Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis 2013 0.91
14 Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment? Gynecol Oncol 2009 0.90
15 Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Crit Rev Oncol Hematol 2009 0.90
16 Randomized comparison of vaginal self-sampling by standard vs. dry swabs for human papillomavirus testing. BMC Cancer 2013 0.90
17 Use of automated primary screening on liquid-based, thin-layer preparations. Acta Cytol 2002 0.89
18 GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach. J Oncol 2012 0.89
19 How to improve cervical cancer screening in Switzerland? Swiss Med Wkly 2012 0.89
20 Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer 2014 0.89
21 Female Genital Mutilation: A Visual Reference and Learning Tool for Health Care Professionals. Obstet Gynecol 2016 0.88
22 Feasibility of at-home self-sampling for HPV testing as an appropriate screening strategy for nonparticipants in Switzerland: preliminary results of the DEPIST study. J Low Genit Tract Dis 2015 0.87
23 A pelvic mass on ultrasonography and high human chorionic gonadotropin level: not always an ectopic pregnancy. BMJ Case Rep 2012 0.86
24 Anatomic distribution of posterior deeply infiltrating endometriosis on MRI after vaginal and rectal gel opacification. AJR Am J Roentgenol 2009 0.85
25 HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. Int J Cancer 2014 0.85
26 Heat shock proteins in ovarian cancer: a potential target for therapy. Gynecol Oncol 2010 0.85
27 Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting. Int J Cancer 2014 0.85
28 Endometriosis-Associated Abdominal Wall Cancer: A Poor Prognosis? Int J Gynecol Cancer 2015 0.84
29 Purified autoantibodies against glucose-regulated protein 78 (GRP78) promote apoptosis and decrease invasiveness of ovarian cancer cells. Cancer Lett 2011 0.84
30 Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix. J Clin Microbiol 2010 0.82
31 Clitoral reconstruction after female genital mutilation/cutting: case studies. J Sex Med 2014 0.79
32 GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78. Target Oncol 2012 0.79
33 [Cervical cancer screening in the French-speaking part of Switzerland: contrasted trajectories]. Rev Med Suisse 2015 0.78
34 Influence of misoprostol or prostaglandin E(2) for induction of labor on the incidence of pathological CTG tracing: a randomized trial. Eur J Obstet Gynecol Reprod Biol 2004 0.78
35 Concordance between core needle biopsy and surgical excision specimens for tumour hormone receptor profiling according to the 2011 St. Gallen Classification, in clinical practice. Breast J 2013 0.78
36 The bright side of ascites in ovarian cancer. Cell Cycle 2014 0.78
37 Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development. Eur J Cancer Prev 2010 0.78
38 Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence. Gynecol Obstet Invest 2008 0.77
39 Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancy. Acta Obstet Gynecol Scand 2003 0.77
40 Pictorial review: rectosigmoid endometriosis on MRI with gel opacification after rectosigmoid colon cleansing. Clin Imaging 2012 0.77
41 Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer. Int J Gynaecol Obstet 2008 0.76
42 Why do ovarian cancer patients not consult a gynecologic oncologist? Gynecol Oncol 2002 0.76
43 Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer? Biochimie 2012 0.76
44 Non-invasive modalities for predicting lymph node spread in early stage endometrial cancer? Surg Oncol 2011 0.75
45 Reconstructive surgery for female genital mutilation. Lancet 2012 0.75
46 Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol 2003 0.75
47 Is the field of breast imaging moving toward broader use of MR imaging? Radiology 2008 0.75
48 Importance of the general practitioner in the early detection of ovarian cancer. Gynecol Oncol 2003 0.75
49 Advancing women's cancer care. Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, Calif., USA, March 22-26, 2006. Gynakol Geburtshilfliche Rundsch 2006 0.75
50 [Gynecology]. Rev Med Suisse 2009 0.75
51 [Education in gynecologic surgery]. Rev Med Suisse 2012 0.75
52 Fertility preservation in cancer patients. Review of the French speaking part of Switzerland and recommendations for different situations. Swiss Med Wkly 2012 0.75
53 [Cervical cancer prevention in Switzerland: the challenges of the vaccine era]. Rev Med Suisse 2012 0.75
54 Silent colo-uterine fistula in an elderly woman. J Am Geriatr Soc 2004 0.75
55 Is imaging relevant for treatment choice in early stage cervical uterine cancer? Surg Oncol 2011 0.75
56 [Diagnosis and management of vulvar intraepithelial neoplasias and invasive vulvar cancers]. Gynakol Geburtshilfliche Rundsch 2007 0.75
57 [Fast track in gynecological surgery]. Rev Med Suisse 2012 0.75
58 [Management of post-coital bleeding: should all women be referred?]. Rev Med Suisse 2013 0.75
59 Role of sonography in the diagnostic workup of ovarian and adnexal masses except in pregnancy and during ovarian stimulation. J Clin Ultrasound 2012 0.75
60 Normal pregnancy or neoplasia? BMJ 2008 0.75
61 [Cervical cancer screening in Switzerland - current practice and future challenges]. Ther Umsch 2013 0.75
62 Posttraumatic Stress Disorder Relapse and Clitoral Reconstruction After Female Genital Mutilation. Obstet Gynecol 2017 0.75
63 Should we modify the current FIGO staging system for early-stage cervical cancer? Expert Rev Anticancer Ther 2008 0.75